About
Technology
Issues
FAQ
Links
Official Page
Tumor burden, inflammation, and product attributes determine outcomes of axicabtagene ciloleucel in large B-cell lymphoma
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.